Biochemical modulation of 5-fluorouracil by leucovorin with or without interferon- -2c in patients with advanced colorectal cancer: final results of a randomised phase III study

By Hausmaninger H.   Moser R.   Samonigg H.   Mlineritsch B.   Schmidt H.   Pecherstorfer M.   Fridrik M.   Kopf C.   Nitsche D.   Kaider A.   Ludwig H.  

European Journal of Cancer, Vol. 35, Iss. 3, 1999-03 ,pp. : 380-385

Elsevier

Access to resources Recommend Favorite

Protracted venous infusion 5-fluorouracil in combination with subcutaneous interleukin-2 and alpha-interferon in patients with metastatic renal cell cancer - a phase II study.

By Allen M.   Vaughan M.   Webb A.   Johnston S.   Savage P.   Eisen T.   Bates S.   Morre J.   Ahern R.   Gore M.  

Urologic Oncology: Seminars and Original Investigations, Vol. 7, Iss. 2, 2002-03 ,pp. : 83-83

Elsevier

Access to resources Recommend Favorite

Phase I study of CPT-11 and bolus 5-FU/l-leucovorin in patients with metastatic colorectal cancer

By Fujishima Hiromitsu   Kikuchi Ikuo   Miyanaga Osamu   Ueda Akira   Baba Eishi   Mitsugi Kenji   Harada Mine   Nakano Shuji  

International Journal of Clinical Oncology, Vol. 9, Iss. 2, 2004-04 ,pp. : 92-97

Springer Publishing Company

Access to resources Recommend Favorite

13-Cis-retinoic Acid and Alpha-interferon in Advanced Squamous Cell Cancer of the Oesophagus

By Kok T.C.   van der Gaast A.   Splinter T.A.W.  

European Journal of Cancer, Vol. 33, Iss. 1, 1997-01 ,pp. : 165-166

Elsevier

Access to resources Recommend Favorite

Docetaxel, 5-fluorouracil, and leucovorin as treatment for advanced gastric cancer: results of a phase II study

By Constenla Manuel   Garcia-Arroyo Ramon   Lorenzo Isabel   Carrete Nancy   Campos Begoña   Palacios Patricia  

Gastric Cancer, Vol. 5, Iss. 3, 2002-09 ,pp. : 142-147

Springer Publishing Company

Access to resources Recommend Favorite